Stock Groups

U.S. FDA vaccine advisers vote in favor of COVID-19 booster shot for those 65 and older By Reuters

[ad_1]

© Reuters. Older people are waiting to be vaccinated with AstraZeneca or Pfizer BioNTech coronavirus diseases (COVID-19), as Chile launches a booster vaccine campaign. The vaccinations will take place in Valparaiso in Chile on August 11th, 2021. REUTERS/Rodrigo G

(Reuters) – A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of illness, after rejecting a call for broader approval.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are provided by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of the potential risks and financial costs involved in trading the financial market. It is among the most risky forms of investment.

[ad_2]